TNDM - Truist bullish on diabetes companies citing potential market growth
2025-06-16 11:24:21 ET
More on DexCom, Insulet, Tandem
- Tandem Diabetes Care: A Barbell Bet On A High-Stakes Turnaround
- Insulet Corporation: Shares Remain Astronomically Expensive
- DexCom Q1 Earnings: Organic Revenue Growth Versus Cost Pressure
- Tandem, Abbott in deal to combine insulin delivery with glucose-ketone sensor
- Tandem to pay Roche $36M in patent dispute settlement